Management of ibrutinib treatment in patients with B-cell malignancies: clinical practice in Portugal and multidisciplinary recommendations-Reference-Cited by-同舟云学术

Management of ibrutinib treatment in patients with B-cell malignancies: clinical practice in Portugal and multidisciplinary recommendations

Published:2021-01-01 Issue:1 Volume:26 Page:785-798
ISSN:1607-8454
Container-title:Hematology
language:en
Short-container-title:Hematology

Author:

Carda José Pedro¹^ORCID,Santos Lurdes²³^ORCID,Mariz José Mário⁴^ORCID,Monteiro Pedro⁵^ORCID,Gonçalves Humberto Miguel⁶,Raposo João⁷,Gomes da Silva Maria⁸^ORCID

Affiliation:

1. Serviço de Hematologia Clínica, Faculdade de Medicina da Universidade de Coimbra, Centro Hospitalar e Universitário de Coimbra, Coimbra Institute for Clinical and Biomedical Research (iCBR), Coimbra, Portugal

2. Centro Hospitalar Universitário de São João, Faculdade de Medicina, Universidade do Porto, Porto, Portugal

3. Nephrology and Infectious Diseases R&D, I3S – Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal

4. Onco-Haematology Clinic, Instituto Português de Oncologia do Porto, EPE/IPOFG – CRO, Porto, Portugal

5. Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal

6. Serviço Farmacêutico, Instituto Português de Oncologia de Lisboa, Francisco Gentil, Lisboa, Portugal

7. Centro Hospitalar Universitário Lisboa Norte, EPE, Lisboa, Portugal

8. Instituto Português de Oncologia de Lisboa, Francisco Gentil, EPE, Lisbon, Portugal

Publisher

Informa UK Limited

Subject

Hematology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/16078454.2021.1980690

Reference92 articles.

1. Chronic lymphocytic leukaemia: from genetics to treatment

2. Inhibition of the Bruton Tyrosine Kinase Pathway in B-Cell Lymphoproliferative Disorders

3. Bruton’s tyrosine kinase (BTK) function is important to the development and expansion of chronic lymphocytic leukemia (CLL)

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chronic Lymphocytic Leukemia: Management of Adverse Events in the Era of Targeted Agents;Cancers;2024-05-24

2. Management of Hematologic Malignancies in the Era of COVID-19 Pandemic: Pathogenetic Mechanisms, Impact of Obesity, Perspectives, and Challenges;Cancers;2022-05-19